# GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/grik2-is-a-target-for-bladder-cancer-stem-like-cell-targeting-immunotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haruka Miyata,Yoshihiko Hirohashi,Shuhei Yamada,Junko Yanagawa,Aiko Murai,Shinichi Hashimoto,Serina Tokita,Kanta Hori,Takashige Abe,Terufumi Kubo,Tomohide Tsukahara,Takayuki Kanaseki,Nobuo Shinohara,Toshihiko Torigoe |
| Citations | 28 |
| DOI | 10.1007/s00262-021-03025-z |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/10992913 |
| OpenAlex ID | https://openalex.org/W3195294034 |
| PMID | 34405274 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Haruka Miyata](https://scholariq.org/researchers/haruka-miyata/)

## Paper primary topic

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Paper topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.